High-risk heart stent procedure study
Part of Heart & circulation clinical trials.
This study tests a new device to help people with high-risk blockages in their heart arteries during a stent procedure. It compares the new device to standard treatment to see if it is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to have a non-emergency heart stent procedure for a blockage in a heart artery or bypass graft.
- A team of heart doctors (including a heart surgeon) has decided that a high-risk stent procedure is right for you.
- You have not had a stroke with lasting problems, or a stroke or mini-stroke within the last 3 months.
- You do not need to stop taking blood thinners or anti-clotting medications within 90 days of the procedure.
- You are not on dialysis and do not have a known blood clotting disorder.
- You are not allergic to nickel, heparin, or contrast dye, and do not have an active infection or fever.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.
This study looks at using a temporary heart pump called Impella ECP during planned high-risk heart stent procedures (PCI). It may help doctors support the heart more safely while placing the stents.
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
This trial tests whether a small heart-support device called Impella CP helps protect your heart during complex coronary angioplasty (a procedure to open blocked heart arteries). You may qualify if you have weak heart function and specific patterns of blocked arteries that make the procedure higher risk.
This trial tests a new device called the Supira system to support the heart during a high-risk procedure to open blocked arteries. It is for people who are stable enough to wait for the procedure (not in emergency or shock).
This study tracks patients with weakened heart function who undergo complex stent procedures (PCI) instead of open-heart surgery. Researchers will follow your progress to understand how well these procedures work in patients who are too sick for traditional bypass surgery.
Hear when a new High-Risk Percutaneous Coronary Intervention (High-risk PCI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.